Jonathan Young, Chief Operating Officer at Akero Therapeutics, Inc. (AKRO), sold 10,000 shares at $27.23 ($268K) on 2024-08-01, disclosed to the SEC on 2024-08-02.
Scheduled sale ($268k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.44 | 3,031 | $80K | 30.0% |
| 2 | $26.44 | 3,031 | $80K | 30.0% |
| 3 | $27.23 | 1,969 | $54K | 20.0% |
| 4 | $27.23 | 1,969 | $54K | 20.0% |
| Total | $26.75 avg | 10,000 | $268K | 100% |
| Filing → |
| AKRO | SELL | 2025-09-04 | $705K | — | Filing → |
| AKRO | SELL | 2025-08-13 | $1.2M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $159K | — | Filing → |